Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Cabozantinib real-world effectiveness in the first...
Conference

Cabozantinib real-world effectiveness in the first through fourth-line settings for the treatment of metastatic renal cell carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC)

Authors

Gan CL; Dudani S; Wells C; Donskov F; Pal SK; Dizman N; Rathi N; Beuselinck B; Yan F; Lalani A-KA

Volume

38

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Publication Date

February 20, 2020

Name of conference

Genitourinary Cancers Symposium of the American-Society-of-Clinical-Oncology (ASCO)

Conference place

CA, San Francisco

Conference start date

February 13, 2020

Conference end date

February 15, 2020

Conference proceedings

JOURNAL OF CLINICAL ONCOLOGY

Issue

6

ISSN

0732-183X

Labels

Fields of Research (FoR)